Skip to main content

Table 2 Patients Characteristics and prevalence of circulating tumor cells

From: Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer

Characteristics No. CTCs (CTC Units/5 ml)
Epithelial CTCs Mixed CTCs Mesenchymal CTCs Total CTCs
M P25-P75 P M P25-P75 P M P25-P75 P M P25-P75 P
Benign lung diseases 38 0 0-0 <  0.01 0 0-0 <  0.01 0 0-0 0.013 0 0-0 < 0.01
NSCLC 98 1 0-2   1 0-3   0 0-1   3 1-6  
Pathological type     0.845    0.528    0.904    0.579
 AC 60 1 0-2.75   1.5 0-3   0 0-1   3 1-6  
 SC 33 1 0-2   1 0-2   2 0-0.5   2 1-5  
 Others 5 1 0.5-3   2 0-3   1 0.5-1   2 1-7  
TNM stage     0.850    0.954    0.505    0.926
 I 48 1 0-2   1 0-3   0 0-1   3 1-6  
 II 13 1 0.5-3   1 0-4   0 0-1   3 1-11  
 III 29 1 0-2.5   1 0-3   0 0-0.5   3 1-6  
 IV 8 1.5 0-4.5   1 0.25-5   0.5 0-1.75   3 0.25-12.75  
Age              
  ≤ 60y 74 1 0-2 0.446 1 0-3 0.470 0 0-1 0.353 3 1-6 1
  > 60y 24 1 0-2   0 0-3.75   0 0-0   2.5 0-6  
  1. Abbreviations: NSCLC non-small cell lung cancer, AC Adenocarcinoma, SC Squamous carcinoma, CTCs circulating tumor cells, M median, P25-P75 inter-quartile range